Concepedia

Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy

Kohei Fujita, Young Hak Kim, Osamu Kanai, Hironori Yoshida, Tadashi Mio, Toyohiro Hirai

Respiratory Medicine · 2018 · 109 citations · 9 references

DOI

Concepts

References

9

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text

, , +17

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie R. Brahmer, Karen L. Reckamp, Lucio Crinò et al. · New England Journal of Medicine · 2015 · 8.6K citations · Full text

, , +15

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst, Dong‐Wan Kim, Enriqueta Felip et al. · The Lancet · 2015 · 6.5K citations

, , +14

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

Cheryl L. Day, Daniel E. Kaufmann, Photini Kiepiela et al. · Nature · 2006 · 2.6K citations

, , +17

The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma

María del Carmen López Castillo, Fabián Andrés Rosas Romero, Esther Argüello et al. · Clinical Infectious Diseases · 2016 · 287 citations · Full text

, , +12